The periaqueductal gray contributes to bidirectional enhancement of antinociception between morphine and cannabinoids

Pharmacology Biochemistry and Behavior

Volumn 103, Issue 3, 2013, Pages 444-449

  Wilson Poe, Adrianne R ^a   Pocius, Edvinas ^a   Herschbach, Melissa ^a   Morgan, Michael M ^a  

^a WASHINGTON STATE UNIVERSITY   (United States)

Author keywords

Analgesia; Cannabinoid; Morphine; Opioid; Periaqueductal gray; Rostral ventromedial medulla

Indexed keywords

CANNABINOID DERIVATIVE; DEXANABINOL; MORPHINE; OPIATE; TETRAHYDROCANNABINOL;

ANALGESIA; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG EFFECT; DRUG MECHANISM; DRUG POTENCY; DRUG POTENTIATION; DRUG SOLUBILITY; MALE; MEDULLA OBLONGATA; MICROINJECTION; NOCICEPTION; NONHUMAN; PERIAQUEDUCTAL GRAY MATTER; PRIORITY JOURNAL; RAT; ROSTRAL VENTROMEDIAL MEDULLA;

ANALGESICS; ANIMALS; BENZOXAZINES; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SYNERGISM; INJECTIONS, SUBCUTANEOUS; MALE; MEDULLA OBLONGATA; MICROINJECTIONS; MORPHINE; MORPHOLINES; NAPHTHALENES; PAIN MEASUREMENT; PERIAQUEDUCTAL GRAY; RATS; RATS, SPRAGUE-DAWLEY; TETRAHYDROCANNABINOL;

RATTUS;

EID: 84868217579     PISSN: 00913057     EISSN: 18735177     Source Type: Journal    
DOI: 10.1016/j.pbb.2012.10.002     Document Type: Article

References (54)

1. D.I. Abrams, P. Couey, S.B. Shade, M.E. Kelly, and N.L. Benowitz Cannabinoid-opioid interaction in chronic pain Clin Pharmacol Ther 90 2011 844 851
2. N.M. Barbaro, M.M. Heinricher, and H.L. Fields Putative pain modulating neurons in the rostral ventral medulla: reflex-related activity predicts effects of morphine Brain Res 366 1986 203 210
3. E.N. Bobeck, A.L. McNeal, and M.M. Morgan Drug dependent sex-differences in periaqueducatal gray mediated antinociception in the rat Pain 147 2009 210 216
4. D.L. Cichewicz Synergistic interactions between cannabinoid and opioid analgesics Life Sci 74 2004 1317 1324 (Pubitemid 38045526)
5. D.L. Cichewicz, and E.A. McCarthy Antinociceptive synergy between delta(9)-tetrahydrocannabinol and opioids after oral administration J Pharmacol Exp Ther 304 2003 1010 1015 (Pubitemid 36254412)
6. D.L. Cichewicz, and S.P. Welch Modulation of oral morphine antinociceptive tolerance and naloxone-precipitated withdrawal signs by oral delta 9-tetrahydrocannabinol J Pharmacol Exp Ther 305 2003 812 817 (Pubitemid 36617955)
7. D.L. Cichewicz, Z.L. Martin, F.L. Smith, and S.P. Welch Enhancement of mu opioid antinociception by oral delta9-tetrahydrocannabinol: dose-response analysis and receptor identification J Pharmacol Exp Ther 289 1999 859 867 (Pubitemid 29191243)
8. D.L. Cichewicz, S.P. Welch, and F.L. Smith Enhancement of transdermal fentanyl and buprenorphine antinociception by transdermal delta9- tetrahydrocannabinol Eur J Pharmacol 525 2005 74 82 (Pubitemid 41689024)
9. 2 + channel currents of acutely dissociated rat periaqueductal grey neurons J Physiol 509 Pt 1 1998 47 58 (Pubitemid 28252010)
10. M.L. Cox, V.L. Haller, and S.P. Welch Synergy between delta9-tetrahydrocannabinol and morphine in the arthritic rat Eur J Pharmacol 567 2007 125 130 (Pubitemid 46782831)
11. A. De Laurentiis, J. Fernandez-Solari, C. Mohn, B. Burdet, M.A. Zorrilla Zubilete, and V. Rettori The hypothalamic endocannabinoid system participates in the secretion of oxytocin and tumor necrosis factor-alpha induced by lipopolysaccharide J Neuroimmunol 221 2010 32 41
12. X.L. Fan, J.S. Zhang, X.Q. Zhang, and L. Ma Chronic morphine treatment and withdrawal induce up-regulation of c-Jun N-terminal kinase 3 gene expression in rat brain Neuroscience 122 2003 997 1002 (Pubitemid 37485849)
13. D.P. Finn, M.D. Jhaveri, S.R. Beckett, C.H. Roe, D.A. Kendall, and C.A. Marsden Effects of direct periaqueductal grey administration of a cannabinoid receptor agonist on nociceptive and aversive responses in rats Neuropharmacology 45 2003 594 604 (Pubitemid 36980816)
14. D.P. Finn, S.R. Beckett, C.H. Roe, A. Madjd, K.C. Fone, and D.A. Kendall Effects of coadministration of cannabinoids and morphine on nociceptive behaviour, brain monoamines and HPA axis activity in a rat model of persistent pain Eur J Neurosci 19 2004 678 686 (Pubitemid 38241307)
15. B. Frank, M.G. Serpell, J. Hughes, J.N. Matthews, and D. Kapur Comparison of analgesic effects and patient tolerability of nabilone and dihydrocodeine for chronic neuropathic pain: randomised, crossover, double blind study BMJ 336 2008 199 201 (Pubitemid 351212676)
16. G.D. Gamble, and R.J. Milne Repeated exposure to sham testing procedures reduces reflex withdrawal and hot-plate latencies: Attenuation of tonic descending inhibition? Neurosci Lett 96 1989 312 317 (Pubitemid 19026699)
17. M.M. Heinricher, and V. Tortorici Interference with GABA transmission in the rostral ventromedial medulla: disinhibition of off-cells as a central mechanism of nociceptive modulation Neuroscience 63 1994 533 546 (Pubitemid 24357376)
18. M.M. Heinricher, M.M. Morgan, V. Tortorici, and H.L. Fields Disinhibition of off-cells and antinociception produced by an opioid action within the rostral ventromedial medulla Neuroscience 63 1994 279 288 (Pubitemid 24333967)
19. A.G. Hohmann, K. Tsou, and J.M. Walker Intrathecal cannabinoid administration suppresses noxious stimulus-evoked Fos protein-like immunoreactivity in rat spinal cord: comparison with morphine Zhongguo Yao Li Xue Bao 20 1999 1132 1136
20. A.C. Howlett Pharmacology of cannabinoid receptors Annu Rev Pharmacol Toxicol 35 1995 607 634
21. A.C. Howlett, L.C. Blume, and G.D. Dalton CB(1) cannabinoid receptors and their associated proteins Curr Med Chem 17 2010 1382 1393
22. S.L. Ingram, C.W. Vaughan, E.E. Bagley, M. Connor, and M.J. Christie Enhanced opioid efficacy in opioid dependence is caused by an altered signal transduction pathway J Neurosci 18 1998 10269 10276 (Pubitemid 29016546)
23. D.A. Lane, and M.M. Morgan Antinociceptive tolerance to morphine from repeated nociceptive testing in the rat Brain Res 1047 2005 65 71 (Pubitemid 40805031)
24. J. Lawston, A. Borella, J.K. Robinson, and P.M. Whitaker-Azmitia Changes in hippocampal morphology following chronic treatment with the synthetic cannabinoid WIN 55,212-2 Brain Res 877 2000 407 410
25. A.H. Lichtman, S.A. Cook, and B.R. Martin Investigation of brain sites mediating cannabinoid-induced antinociception in rats: evidence supporting periaqueductal gray involvement J Pharmacol Exp Ther 276 1996 585 593
26. W.J. Martin, S.L. Patrick, P.O. Coffin, K. Tsou, and J.M. Walker An examination of the central sites of action of cannabinoid-induced antinociception in the rat Life Sci 56 1995 2103 2109
27. W.J. Martin, K. Tsou, and J.M. Walker Cannabinoid receptor-mediated inhibition of the rat tail-flick reflex after microinjection into the rostral ventromedial medulla Neurosci Lett 242 1998 33 36 (Pubitemid 28122702)
28. I.D. Meng, and J.P. Johansen Antinociception and modulation of rostral ventromedial medulla neuronal activity by local microinfusion of a cannabinoid receptor agonist Neuroscience 124 2004 685 693 (Pubitemid 38251333)
29. I.D. Meng, B.H. Manning, W.J. Martin, and H.L. Fields An analgesia circuit activated by cannabinoids Nature 395 1998 381 383 (Pubitemid 28450687)
30. M.M. Morgan, and M.J. Christie Analysis of opioid efficacy, tolerance, addiction and dependence from cell culture to human Br J Pharmacol 164 2011 1322 1334
31. M.M. Morgan, and P.K. Whitney Immobility accompanies the antinociception mediated by the rostral ventromedial medulla of the rat Brain Res 872 2000 276 281 (Pubitemid 30618920)
32. M.M. Morgan, B.W. Tierney, and S.L. Ingram Intermittent dosing prolongs tolerance to the antinociceptive effect of morphine microinjection into the periaqueductal gray Brain Res 1059 2005 173 178 (Pubitemid 41457315)
33. M.M. Morgan, E.N. Fossum, C.S. Levine, and S.L. Ingram Antinociceptive tolerance revealed by cumulative intracranial microinjections of morphine into the periaqueductal gray in the rat Pharmacol Biochem Behav 85 2006 214 219 (Pubitemid 44772923)
34. M.M. Morgan, K.L. Whittier, D.M. Hegarty, and S.A. Aicher Periaqueductal gray neurons project to spinally projecting GABAergic neurons in the rostral ventromedial medulla Pain 140 2008 376 386
35. P. Mukhopadhyay, H. Pan, M. Rajesh, S. Batkai, V. Patel, and J. Harvey-White CB1 cannabinoid receptors promote oxidative/nitrosative stress, inflammation and cell death in a murine nephropathy model Br J Pharmacol 160 2010 657 668
36. Z.Z. Pan, J.T. Williams, and P.B. Osborne Opioid actions on single nucleus raphe magnus neurons from rat and guinea-pig in vitro J Physiol 427 1990 519 532 (Pubitemid 20256740)
37. G. Paxinos, and S.J. Watson The rat brain, in stereotaxic coordinates 2nd ed. 2005 Academic Press Sydney
38. R.G. Pertwee Pharmacology of cannabinoid CB1 and CB2 receptors Pharmacol Ther 74 1997 129 180 (Pubitemid 27337346)
39. J.D. Roberts, C. Gennings, and M. Shih Synergistic affective analgesic interaction between delta-9-tetrahydrocannabinol and morphine Eur J Pharmacol 530 2006 54 58 (Pubitemid 43037124)
40. T. Rubino, L. Tizzoni, D. Vigano, P. Massi, and D. Parolaro Modulation of rat brain cannabinoid receptors after chronic morphine treatment Neuroreport 8 1997 3219 3223 (Pubitemid 27461370)
41. D. Rueda, I. Galve-Roperh, A. Haro, and M. Guzman The CB(1) cannabinoid receptor is coupled to the activation of c-Jun N-terminal kinase Mol Pharmacol 58 2000 814 820
42. A.C. Scallet Neurotoxicology of cannabis and THC: A review of chronic exposure studies in animals Pharmacol Biochem Behav 40 1991 671 676
43. F.L. Smith, D. Cichewicz, Z.L. Martin, and S.P. Welch The enhancement of morphine antinociception in mice by delta9-tetrahydrocannabinol Pharmacol Biochem Behav 60 1998 559 566 (Pubitemid 28282699)
44. R.J. Tallarida Drug synergism and dose-effect data analysis 2000 Chapman & Hall/CRC Boca Raton
45. S.M. Tham, J.A. Angus, E.M. Tudor, and C.E. Wright Synergistic and additive interactions of the cannabinoid agonist CP55,940 with mu opioid receptor and alpha2-adrenoceptor agonists in acute pain models in mice Br J Pharmacol 144 2005 875 884 (Pubitemid 40516127)
46. V. Tortorici, C.S. Robbins, and M.M. Morgan Tolerance to the antinociceptive effect of morphine microinjections into the ventral but not lateral-dorsal periaqueductal gray of the rat Behav Neurosci 113 1999 833 839 (Pubitemid 29426702)
47. C.W. Vaughan, and M.J. Christie Presynaptic inhibitory action of opioids on synaptic transmission in the rat periaqueductal grey in vitro J Physiol 498 Pt 2 1997 463 472 (Pubitemid 27073390)
48. C.W. Vaughan, I.S. McGregor, and M.J. Christie Cannabinoid receptor activation inhibits GABAergic neurotransmission in rostral ventromedial medulla neurons in vitro Br J Pharmacol 127 1999 935 940 (Pubitemid 29295353)
49. S.P. Welch, and D.L. Stevens Antinociceptive activity of intrathecally administered cannabinoids alone, and in combination with morphine, in mice J Pharmacol Exp Ther 262 1992 10 18
50. S.P. Welch, C. Thomas, and G.S. Patrick Modulation of cannabinoid-induced antinociception after intracerebroventricular versus intrathecal administration to mice: possible mechanisms for interaction with morphine J Pharmacol Exp Ther 272 1995 310 321
51. I.J. Williams, S. Edwards, A. Rubo, V.L. Haller, D.L. Stevens, and S.P. Welch Time course of the enhancement and restoration of the analgesic efficacy of codeine and morphine by delta9-tetrahydrocannabinol Eur J Pharmacol 539 2006 57 63 (Pubitemid 44208807)
52. A. Wilson, L. Maher, and M. Morgan Repeated cannabinoid injections into the rat periaqueductal gray enhance subsequent morphine antinociception Neuropharmacology 55 2008 1219 1225
53. A.R. Wilson-Poe, M.M. Morgan, S.A. Aicher, and D.M. Hegarty Distribution of CB1 cannabinoid receptors and their relationship with mu-opioid receptors in the rat periaqueductal gray Neuroscience 213 2012 191 200
54. Q. Yang, H.Y. Liu, Y.W. Zhang, W.J. Wu, and W.X. Tang Anandamide induces cell death through lipid rafts in hepatic stellate cells J Gastroenterol Hepatol 25 2010 991 1001